FDA Approves 'Rapid-Acting' Oral Drug for Major Depression :

The US Food and Drug Administration has approved dextromethorphan-bupropion (Auvelity), the first for an NMDA receptor antagonist for the treatment of major depressive disorder in adults.

Related Keywords

Boston , Massachusetts , United States , , Drug Administration , N Methyld Aspartate , Axsome Therapeutics , Massachusetts General Hospital , Depression , Drug Development , Recurrent Major Depression , Major Depression , Major Depressive Disorder , Nipolar Depression , Antidepressant , Antidepressant Drug , Rug Antidepressant , Us Food And Drug Administration , Nited States Food And Drug Administration , Fda , Acute Pain , Nmda Receptor Antagonist , Pain Management ,